Evidence map›Paper›PMID 26985904›Full record

ReviewNutrients2016

Micronutrients in Oncological Intervention.

Uwe Gröber, Peter Holzhauer, Klaus Kisters, Michael F Holick, Irenäus A Adamietz

Open access · goldAbstract readReview
In one paragraph

Review in Nutrients, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 3 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 3 syntheses or guidelines pooled it, 126 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Article
  7. Review
  8. Review
  9. Awareness and usage of a dietary guide by cancer patients and clinicians: a national survey study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025
    Article
  10. Review
  11. Article
  12. Observational
  13. Article
  14. Observational
  15. Ethnic-specific associations between body mass index and gastric cancer: a Mendelian randomization study in European and Korean populations.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  16. Review
  17. Article
  18. Observational
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Uwe GröberAkademie für Mikronährstoffmedizin, Essen, Zweigertstrasse 55, 45130 Essen, Germany. uwegroeber@gmx.net.
Peter HolzhauerAkademie für Mikronährstoffmedizin, Essen, Zweigertstrasse 55, 45130 Essen, Germany. p.holzhauer@ioz-muenchen.de.
Klaus KistersAkademie für Mikronährstoffmedizin, Essen, Zweigertstrasse 55, 45130 Essen, Germany. klaus.kisters@annahospital.de.
Michael F HolickBoston University Medical Center, 85 East Newton Street M-1033, Boston, MA 02118, USA. mfholick@bu.edu.
Irenäus A AdamietzKlinik für Strahlentherapie und Radio-Onkologie, Ruhr Universität Bochum (RUB), Hölkeskampring 40, Herne 44625, Germany. irenaeus.adamietz@elisabethgruppe.de.
Institut für Medizinische Informatik, Biometrie und Epidemiologie · DEBoston University · USUniversity Hospitals of the Ruhr-University of Bochum · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nutritional supplements are widely used among patients with cancer who perceive them to be anticancer and antitoxicity agents. Depending on the type of malignancy and the gender 30%-90% of the cancer patients supplement their diets with antioxidant and immuno-stabilizing micronutrients, such as selenium, vitamin C, and vitamin D, often without the knowledge of the treating physician. From the oncological viewpoint, there are justifiable concerns that dietary supplements decrease the effectiveness of chemotherapy and radiotherapy. Recent studies, however, have provided increasing evidence that treatment is tolerated better-with an increase in patient compliance and a lower rate of treatment discontinuations-when micronutrients, such as selenium, are added as appropriate to the patient's medication. Nutritional supplementation tailored to an individual's background diet, genetics, tumor histology, and treatments may yield benefits in subsets of patients. Clinicians should have an open dialogue with patients about nutritional supplements. Supplement advice needs to be individualized and come from a credible source, and it is best communicated by the physician.

Indexed as

DietDietary SupplementsNutritional StatusHumansMalnutritionMicronutrientsNeoplasmsPractice Guidelines as TopicProtective FactorsRisk FactorsTreatment OutcomeMicronutrientsantioxidantscancerchemotherapy">l-carnitineMicronutrientsradiotherapyseleniumtreatment related side effectsvitamin Cvitamin D

Identifiers

PMID26985904
PMCPMC4808891
OpenAlexW2293151262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.